Final results of the TALENT trial (GETNE1509): a prospective multicohort phase II study of lenvatinib in patients (pts) with G1/G2 advanced pancreatic (panNETs) and gastrointestinal (giNETs) neuroendocrine tumors (NETs)
Capdevila, J Fazio, N Lopez, CL Teule, A Valle, Juan W Tafuto, S Custodio, AB Reed, N Raderer, M Grande, E
Capdevila, J
Fazio, N
Lopez, CL
Teule, A
Valle, Juan W
Tafuto, S
Custodio, AB
Reed, N
Raderer, M
Grande, E
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Capdevila J, Fazio N, Lopez Lopez C, Teule A, Valle JW, Tafuto S, et al. Final results of the TALENT trial (GETNE1509): a prospective multicohort phase II study of lenvatinib in patients (pts) with G1/G2 advanced pancreatic (panNETs) and gastrointestinal (giNETs) neuroendocrine tumors (NETs). J Clin Oncol. 2019;37(15_suppl):4106-.